97002 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Growth hormones [GH] (Somatotropin)
Sub-classes:Use Of Long-Acting Growth Hormone For Treating Inflammation-Induced Diseases
#2UNNATURAL AMINO ACID AND USE THEREOF, RECOMBINANT PROTEIN CONTAINING SAME AND RECOMBINANT PROTEIN CONJUGATE
#3Multifunctional Multispecific Multimeric Biomolecule Polymer Having Prolonged In-Vivo Duration
#4PEPTIDE-MHC COMPACTS
#5CARBON DIOXIDE-CONSUMING EXPRESSION SYSTEM
#6GROWTH HORMONE RECEPTOR ANTAGONISTS EXHIBITING INCREASED RECEPTOR BINDING PROPERTIES AND INCREASED SERUM HALF-LIFE
#7EXTENDED RECOMBINANT POLYPEPTIDES AND COMPOSITIONS COMPRISING SAME
#8HIGH-CONCENTRATION ADMINISTRATION FORMULATION OF HGH FUSION PROTEIN
#9METHOD FOR CONSTRUCTING STRAIN FOR PRODUCING RECOMBINANT PROTEIN CONTAINING UNNATURAL AMINO ACIDS, AND STRAIN OBTAINED THEREFROM
#10MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE
#11ANTAGONIST FUSION POLYPEPTIDES
#12ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF RETT SYNDROME
#13CELL-FREE METHODS AND COMPOSITIONS COMPRISING TAGLESS THERAPEUTIC HORMONES
#14UNNATURAL AMINO ACID, AND USE THEREOF, RECOMBINANT PROTEIN CONTAINING SAME, AND RECOMBINANT PROTEIN CONJUGATE
#15METHOD FOR PRODUCING FUSION PROTEIN OF SERUM ALBUMIN AND GROWTH HORMONE
#16BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS
#17METHODS OF ADMINISTERING LONG-ACTING GROWTH HORMONE POLYPEPTIDES
#18METHOD FOR PRODUCING FUSION PROTEIN OF SERUM ALBUMIN AND GROWTH HORMONE
#19MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF CYTOPLASMIC AND CYTOSKELETAL PROTEINS
#20GROWTH HORMONE FUSION PROTEIN AND PREPARATION METHOD AND USE THEREOF
#21INTER-APPLICATION WORKFLOW PERFORMANCE ANALYTICS
#22COILED COIL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF
#23METHOD FOR PURIFICATION OF RECOMBINANT PROTEINS
#24METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#25GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF
#26AAV5-BASED VACCINE AGAINST SARS-COV-2
#27GENE THERAPIES FOR LYSOSOMAL DISORDERS
#28Methods and systems for solid phase peptide synthesis
#29METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#30METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#31METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#32METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#33METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#34METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#35SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS
#36Peptide-based inhibitors of growth hormone action and methods of use thereof
#37COMPOSITIONS AND METHODS FOR GENOME ENGINEERING
#38IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS
#39Production and Purification Method for Polypeptide
#40Protease deficient filamentous fungal cells and methods of use thereof
#41Long-Acting Therapeutic Fusion Proteins
#42Long-acting polypeptides and methods of producing and administering same
#43METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#44GENE EXPRESSION CASSETTE FOR EXPRESSING N-TERMINAL METHIONINE-TRUNCATED PROTEIN OF INTEREST AND METHOD FOR PRODUCING N-TERMINAL METHIONINE-TRUNCATED PROTEIN OF INTEREST BY USING SAME
#45ARTIFICIAL RECOMBINANT PROTEIN FOR IMPROVING PERFORMANCE OF ACTIVE PROTEIN OR POLYPEPTIDE AND USE THEREOF
#46CARRIER PROTEIN FOR IMPROVING PROPERTIES OF BIOACTIVE PROTEIN
#47Adeno-associated virus vectors for treatment of Rett syndrome
#48mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
#49Fusion proteins with extended serum half life
#50IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS
#51Cell Expression System
#52METHODS OF PRODUCING LONG ACTING CTP-MODIFIED POLYPEPTIDES
#53FUSION POLYPEPTIDE COMPRISING POLYPEPTIDE REGION THAT CAN BE O-GLYCOSYLATED
#54In vivo protein N-acylation
#55Long-acting fibronectin type III domain fusion protein
#56MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE
#57Polymeric Prodrugs with a Self-Immolative Linker
#58Extended recombinant polypeptides and compositions comprising same
#59Human serum albumin mutant
#60PEGylated recombinant human growth hormone compounds
#61SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS
#62Protease deficient filamentous fungal cells and methods of use thereof
#63COMPOSITION FOR IMPROVING SKIN CONDITIONS COMPRISING A FRAGMENT OF HUMAN HEAT SHOCK PROTEIN 90A AS AN ACTIVE INGREDIENT
#64Radiation-Sterilized Biodegradable Drug Delivery Compositions
#65Peptide-based inhibitors of growth hormone action and methods of use thereof
#66IN VIVO PRODUCTION OF PROTEINS
#67Peptide-MHC compacts
#68Methods and systems for solid phase peptide synthesis
#69Applied Artificial Intelligence Technology for Hormone Therapy Treatment
#70Human growth hormone fusion protein with enhanced thermal stability and cosmetic composition for anti-wrinkle and maintaining skin elasticity comprising the same as effective component
#71Growth hormone receptor antagonists and fusion proteins thereof
#72Therapeutic pegylated growth hormone antagonists
#73DOMINANT NEGATIVE LIGAND CHIMERIC ANTIGEN RECEPTOR SYSTEMS
#74Gene therapies for lysosomal disorders
#75METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#76Gene therapies for lysosomal disorders
#77Gene therapies for lysosomal disorders
#78Coiled coil immunoglobulin fusion proteins and compositions thereof
#79SYSTEMS AND METHODS FOR USING BEHAVIOR DATA OF IMPURITIES AND TARGET PROTEINS TO DESIGN DOWNSTREAM PROCESSES
#80Human serum albumin mutant
#81Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#82METHODS OF TREATMENT WITH LONG-ACTING HORMONE
#83Applied artificial intelligence technology for hormone therapy treatment
#84Growth Hormones with Prolonged In-Vivo Efficacy
#85Immunoglobulin chimeric monomer-dimer hybrids
#86In vivo protein N-acylation
#87Peptide-MHC compacts
#88CELL EXPRESSION SYSTEM
#89METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#90EXPRESSION CONSTRUCT AND METHOD FOR PRODUCING PROTEINS OF INTEREST
#91In vivo production of proteins
#92CYSTEINE VARIANTS OF INTERLEUKIN-11 AND METHODS OF USE THEREOF
#93IgG Fc fragment for a drug carrier and method for the preparation thereof
#94Fusion proteins with extended serum half life
#95Delivery of therapeutic agents by a collagen binding protein
#96Protease deficient filamentous fungal cells and methods of use thereof
#97PHARMACEUTICAL COMPOSITION FOR TREATING GROWTH HORMONE DEFICIENCY CONTAINING hGH FUSION PROTEIN
#98Methods for protein modification in pharmaceutical applications
#99Production of N-glycoproteins for enzyme assisted glycomodification
#100Growth Hormones with Prolonged In-Vivo Efficacy
#101Immunomodulatory polypeptides and related compositions and methods
#102PEGylated recombinant human growth hormone compounds
#103Pegylated growth hormone antagonists
#104Radiation - Sterilized Biodegradable Drug Delivery Compositions
#105Skin probiotic formulation
#106Serum albumin-20K growth hormone fusion protein
#107LIQUID FORMULATION OF HIGHLY CONCENTRATED LONG-ACTING HUMAN GROWTH HORMONE CONJUGATE
#108Composition for improving skin conditions comprising a fragment of human heat shock protein 90A as an active ingredient
#109PROTEIN COMPLEX USING AN IMMUNOGLOBULIN FRAGMENT AND METHOD FOR THE PREPARATION THEREOF
#110STABILIZED BIOACTIVE PEPTIDES AND METHODS OF IDENTIFICATION, SYNTHESIS, AND USE
#111Modified Polynucleotides for the production of biologics and proteins associated with human disease
#112Fractionation of charged polysaccharide
#113Expression of Mammalian Proteins in Pseudomonas Fluorescens
#114Protein conjugates
#115Long-acting polypeptides and methods of producing and administering same
#116Human serum albumin mutant
#117Extended recombinant polypeptides and compositions comprising same
#118MRNA for use in treatment of human genetic diseases
#119ALBUMIN FUSION PROTEINS
#120CELL EXPRESSION SYSTEM
#121EFFICIENT PRODUCTION OF PEPTIDES
#122LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING SAME
#123GROWTH HORMONE POLYPEPTIDES AND METHODS OF MAKING AND USING SAME
#124METHOD FOR PRODUCING MEGAKARYOCYTES, PLATELETS AND/OR THROMBOPOIETIN USING MESENCHYMAL CELLS
#125SINGLE CHAIN Fc-DIMER-HUMAN GROWTH HORMONE FUSION PROTEIN FOR IMPROVED DRUG DELIVERY
#126METHODS OF PRODUCING LONG ACTING CTP-MODIFIED GROWTH HORMONE POLYPEPTIDES
#127METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#128Long-lived polynucleotide molecules
#129TREATMENT WITH HUMAN GROWTH HORMONE ANALOGUES
#130Transgenic microalgae and use thereof for oral delivery of proteins
#131Method of preparing an anti-serum albumin Fab-effector moiety fusion construct
#132Method to increase the number of circulating platelets by administering PEGylated cysteine variants of IL-11
#133Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#134METHODS FOR MAKING PROTEINS CONTAINING FREE CYSTEINE RESIDUES
#135METHODS AND MEANS FOR DETERMINING TREATMENT OF SUBJECTS WITH EXOGENOUS SOMATOTROPIN
#136In vivo production of proteins
#137Protease deficient filamentous fungal cells and methods of use thereof
#138Immunoglobulin chimeric monomer-dimer hybrids
#139Immunoglobulin chimeric monomer-dimer hybrids
#140Delivery of therapeutic agents by a collagen binding protein
#141METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#142ALBUMIN FUSION PROTEINS
#143Growth hormone polypeptides and methods of making and using same
#144SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS
#145Methods and systems for solid phase peptide synthesis
#146Stabilizied bioactive peptides and methods of identification, synthesis and use
#147Expression of mammalian proteins in
#148Extended recombinant polypeptides and compositions comprising same
#149Growth hormone fusion proteins with growth hormone receptor agonist activity
#150Anti-serum albumin Fab-effector moiety fusion construct, and a method of preparing the construct
#151Methods for protein modification in pharmaceutical applications
#152Long-acting polypeptides and methods of producing and administering same
#153Biologically active proteins having increased in vivo and/or in vitro stability
#154Cell expression system
#155METHODS FOR MAKING PROTEINS CONTAINING FREE CYSTEINE RESIDUES
#156IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF
#157PEGylated Recombinant Human Growth Hormone Compounds
#158Methods of preparing cysteine variants of human recombinant IL-11
#159Method for producing megakaryocytes, platelets and/or thrombopoietin using mesenchymal cells
#160Fractionation of charged polysaccharide
#161Fractionation of charged polysaccharide
#162Coiled coil immunoglobulin fusion proteins and compositions thereof
#163ALBUMIN FUSION PROTEINS
#164Polynucleotide encoding a fusion protein for improving skin conditions
#165HUMAN IGG4 FC POLYPEPTIDE VARIANT
#166mRNA for use in treatment of human genetic diseases
#167Method for producing natively folded proteins in a prokaryotic host
#168Modified polynucleotides for the production of biologics and proteins associated with human disease
#169System for expression of genes in plants
#170LONG-LIVED POLYNUCLEOTIDE MOLECULES
#171Cell expression system
#172Growth Hormone Compounds
#173FORMULATIONS OF AN ALBUMIN hGH FUSION PROTEIN
#174THERAPEUTIC PROTEIN COMPOSITIONS HAVING REDUCED IMMUNOGENICITY AND/OR IMPROVED EFFICACY
#175Bovine fusion antibodies
#176Albumin fusion proteins
#177COMPOSITIONS AND METHODS FOR IMPROVING PRODUCTION OF RECOMBINANT POLYPEPTIDES
#178METHOD FOR EXPRESSION, EXTRACTION AND PURIFICATION OF SOLUBLE RECOMBINANT PROTEIN
#179Albumin fusion proteins
#180Long-acting polypeptides and methods of producing same
#181Use of high flux SCFA-derivatized monosaccharides in recombinant glycoprotein production
#182Transgenic microalgae and use thereof for oral delivery of proteins
#183LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME
#184Compositions, methods and uses
#185MODIFIED BOVINE SOMATOTROPIN POLYPEPTIDES AND THEIR USES
#186Long-acting polypeptides and methods of producing same
#187Long-acting polypeptides and methods of producing and administering same
#188Long-acting polypeptides and methods of producing and administering same
#189Methods for treating diseases with peptides that inhibit IGF-1
#190Method of purifying a long-acting human growth hormone
#191Long-acting polypeptides and methods of producing and administering same
#192Liquid formulation of highly concentrated long-acting human growth hormone conjugate
#193Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#194Long-acting polypeptides and methods of producing and administering same
#195Therapeutic agents comprising fusions of growth hormone and elastic peptides
#196Method for manufacturing transdermally delivered hyaluronic acid-protein conjugate and transdermally delivered hyaluronic acid-protein conjugate manufactured using same
#197LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME
#198IgG Fc fragment for a drug carrier and method for the preparation thereof
#199IgG Fc fragment for a drug carrier and method for the preparation thereof
#200Efficient production of peptides
#201mRNA for use in treatment of human genetic diseases
#202Methods of treatment with long-acting growth hormone
#203Growth hormone polypeptides and methods of making and using same
#204Protease deficient filamentous fungal cells and methods of use thereof
#205BIOLOGICALLY ACTIVE PROTEINS HAVING INCREASED IN VIVO AND/OR IN VITRO STABILITY
#206Growth hormone receptor antagonists
#207Extended recombinant polypeptides and compositions comprising same
#208METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#209Radiation-Sterilized Biodegradable Drug Delivery Composition
#210Process for production of recombinant human growth hormone using growth media with added trace elements from cells
#211Bovine fusion antibodies
#212System for expression of genes in plants
#213Therapeutic agents comprising fusions of insulin and elastic peptides
#214DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
#215TREATMENT WITH HUMAN GROWTH HORMONE ANALOGUES
#216Ghrelin analogs
#217Fractionation of charged polysaccharide
#218LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME
#219Growth hormones with prolonged in-vivo efficacy
#220Stabilized bioactive peptides and methods of identification, synthesis, and use
#221GH-RH analogs with potent agonistic effects
#222Growth hormone and interferon-alpha 2 glycoproteins produced in plants
#223Prognosis and risk assessment in stroke patients by determining the level of marker peptides
#224Treatment with factor ix-albumin fusion protein
#225Treatment with factor VII-albumin fusion protein
#226Long-acting polypeptides and methods of producing same
#227Protein complex using an immunoglobulin fragment and method for the preparation thereof
#228Albumin Fusion Proteins
#229Methods for making proteins containing free cysteine residues
#230Long-acting polypeptides and methods of producing and administering same
#231Polymeric prodrug with self-immolative linker
#232GROWTH HORMONE CONJUGATES
#233YEAST HOST, TRANSFORMANT AND METHOD FOR PRODUCING HETEROLOGOUS PROTEINS
#234Serum-free mammalian cell culture medium, and uses thereof
#235METHOD FOR CULTIVATING A TRANSGENIC ANIMAL WITH INCREASED EXPRESSION AMOUNT OF PORCINE GROWTH HORMONE
#236Stable growth hormone compounds resistant to proteolytic degradation
#237COMPOSITIONS AND METHODS FOR IMPROVING PRODUCTION OF RECOMBINANT POLYPEPTIDES
#238Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#239ALBUMIN FUSION PROTEINS
#240Growth hormone fusion proteins
#241THERAPEUTIC AGENTS COMPRISING ELASTIC PEPTIDES
#242Recombinant protein production in heterologous systems
#243METHOD AND COMPOSITION FOR TREATMENT OF SKELETAL DYSPLASIAS
#244MODIFIED GROWTH HORMONE POLYPEPTIDES
#245Growth hormones with prolonged in-vivo efficacy
#246MODIFIED PORCINE SOMATOTROPIN POLYPEPTIDES AND THEIR USES
#247MODIFIED BOVINE SOMATOTROPIN POLYPEPTIDES AND THEIR USES
#248ALBUMIN FUSION PROTEINS
#249Methods of treatment using cysteine variants of interleukin-11
#250BIOLOGICALLY ACTIVE PROTEINS HAVING INCREASED IN VIVO AND/OR IN VITRO STABILITY
#251UNSTRUCTURED RECOMBINANT POLYMERS AND USES THEREOF
#252ISOLATED STROMAL CELLS AND METHODS OF USING THE SAME
#253Method for producing natively folded proteins in a prokaryotic host
#254Modified human interferon polypeptides and their uses
#255mRNA for use in treatment of human genetic diseases
#256Albumin fusion proteins
#257Albumin Fusion Proteins
#258Method for inhibiting growth of chondrocytes in a subject by inhibiting IGF-1
#259Fc fusion proteins of human growth hormone
#260PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS
#261STABLE PHARMACEUTICAL COMPOSITIONS OF PEPTIDE DERIVATIZED USING AN OXIME LINKER
#262System for expression of genes in plants
#263Human Growth Hormone Formulations
#264Polypeptide protracting tags
#265Method for reducing immunogenicity of therapeutic protein compositions
#266Methods for making proteins containing free cysteine residues
#267Stabilized bioactive peptides and methods of identification, synthesis, and use
#268Albumin fusion proteins
#269Production of Biologically Active Proteins
#270Long-acting polypeptides and methods of producing same
#271Long-acting veterinary polypeptides and methods of producing and administering same
#272PROCESS FOR PRODUCING RECOMBINANT PROTEIN USING NOVEL FUSION PARTNER
#273Stable growth hormone compounds resistant to proteolytic degradation
#274Modified Human Growth Hormone
#275Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#276Spacers to increase the expression of recombinant fusion proteins
#277RECOMBINANT FUSION PROTEINS TO GROWTH HORMONE AND SERUM ALBUMIN
#278TREATMENT OF ALPHA-GALACTOSIDASE A DEFICIENCY
#279Albumin Fusion Proteins
#280Method for selectively modifying a protein via transglutaminase catalyzed reaction
#281PROGNOSIS AND RISK ASSESSMENT IN STROKE PATIENTS BY DETERMINING THE LEVEL OF MARKER PEPTIDES
#282Growth Hormone Conjugate with Increased Stability
#283Cysteine variants of interferon gamma
#284Method for the mass production of immunoglobulin constant region
#285POLYMER CONJUGATES OF AOD-LIKE PEPTIDES
#286hGH AND METHODS FOR PREPARING hGH
#287BL21 strain lacking a functional group II capsular gene cluster
#288Glycoproteins Produced in Plants and Methods of Their Use
#289Nucleic acid for plant expression of a fusion protein comprising hydroxyproline O-glycosylation glycomodule
#290Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino Acid
#291Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins
#292Immunoglobulin chimeric monomer-dimer hybrids
#293O-LINKED GLYCOSYLATION USING N-ACETYLGLUCOSAMINYL TRANSFERASES
#294Method of preparing cysteine mutants of human recombinant GM-CSF
#295Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
#296Unstructured recombinant polymers and compositions comprising same
#297Methods for Chemically Synthesizing Immunoglobulin Chimeric Proteins
#298Protein conjugates and methods for their preparation
#299Protease resistant modified IFN beta polypeptides and their use in treating diseases
#300MODIFIED GROWTH HORMONE